Publication Area
RSSArticles
-
FDA, CDC Sign Off on Third COVID-19 Vaccine
Johnson & Johnson’s COVID-19 vaccine is the first single-shot solution to receive an agency emergency use authorization.
-
Tailoring Opioid Prescriptions to Patients’ Perception of Pain
Customized approach led to better pain management and less waste after surgery.
-
Vericiguat Tablets (Verquvo)
Vericiguat is indicated to lower the risk of cardiovascular death and heart failure hospitalization in adults with symptomatic chronic heart failure and an ejection fraction less than 45%.
-
Is There an Ideal Time to Administer Antihypertension Medications?
Taking all antihypertensive agents before bed vs. upon awakening in hypertensive patients showed there was less hypertension during sleep and few cardiovascular events over a six-year follow-up.
-
Time-Restricted Eating, Weight Loss, and Metabolism
A randomized clinical trial comparing time-restricted eating with a 16-hour fasting interval to a structured three-meal-per-day control group resulted in equivalent weight loss in both groups and no reduction in metabolic markers in either group.
-
Healthy or Not: The Controversy Over Egg Consumption Continues
A large meta-analysis showed higher consumption of eggs (eating more than one egg daily) was not associated with an increased risk of cardiovascular disease, and was associated with a lower risk of coronary artery disease.
-
One Dose, Lower Temps May Suffice for Pfizer/BioNTech COVID-19 Vaccine
Encouraging new data emerge regarding storage, administration requirements.
-
U.K. Approves First COVID-19 Human Challenge Trial
Volunteers will be infected with virus so researchers can learn more about pathology, speed effective vaccine development.
-
Obesity Connected to Up to Half of All U.S. Diabetes Cases
Recent analysis reveals strong connection between body weight and type 2 diabetes.
-
Feds Redefine Who Can Handle COVID-19 Vaccine
HHS expands list of who can prescribe, dispense, and administer shots.